578 related articles for article (PubMed ID: 9490097)
1. S-100 and NSE as serum markers in melanoma.
Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
[TBL] [Abstract][Full Text] [Related]
4. Neuron-specific enolase as a tumor marker in metastatic melanoma.
Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
Wibe E; Hannisdal E; Paus E; Aamdal S
Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
[TBL] [Abstract][Full Text] [Related]
6. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Wibe E; Paus E; Aamdal S
Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
[TBL] [Abstract][Full Text] [Related]
7. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
Hornef S; Lux J; Rassner G
Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
[TBL] [Abstract][Full Text] [Related]
8. Analysing the serum levels of tumour markers and primary tumour data in stage III melanoma patients in correlation to the extent of lymph node metastases--a prospective study in 231 patients.
Neuss H; Koplin G; Raue W; Reetz C; Mall JW
Acta Chir Belg; 2011; 111(4):214-8. PubMed ID: 21954736
[TBL] [Abstract][Full Text] [Related]
9. Serum S-100 has prognostic significance in malignant melanoma.
Bonfrer JM; Korse CM; Israels SP
Anticancer Res; 1997; 17(4B):2975-7. PubMed ID: 9329579
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
11. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
12. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
[TBL] [Abstract][Full Text] [Related]
13. [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].
Uerlich M; Biltz H; Kreysel HW
Immun Infekt; 1988 Apr; 16(2):65-7. PubMed ID: 3292403
[TBL] [Abstract][Full Text] [Related]
14. Serum concentration of NSE and S-100b during LVAD in non-resuscitated patients.
Pfeifer R; Ferrari M; Börner A; Deufel T; Figulla HR
Resuscitation; 2008 Oct; 79(1):46-53. PubMed ID: 18617311
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures.
Büttner T; Lack B; Jäger M; Wünsche W; Kuhn W; Müller T; Przuntek H; Postert T
J Neurol; 1999 Jun; 246(6):459-61. PubMed ID: 10431771
[TBL] [Abstract][Full Text] [Related]
16. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.
Brea D; Sobrino T; Blanco M; Cristobo I; Rodríguez-González R; Rodríguez-Yañez M; Moldes O; Agulla J; Leira R; Castillo J
Clin Chem Lab Med; 2009; 47(12):1513-8. PubMed ID: 19863297
[TBL] [Abstract][Full Text] [Related]
17. Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma.
Mårtenson ED; Hansson LO; Nilsson B; von Schoultz E; Månsson Brahme E; Ringborg U; Hansson J
J Clin Oncol; 2001 Feb; 19(3):824-31. PubMed ID: 11157036
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of s-100 protein and neuron-specific enolase as serum markers for cerebral deficiency after general anesthesia. Study in patient with hip or knee replacement].
Linstedt U; Kropp P; Möller C; Zenz M
Anaesthesist; 2000 Oct; 49(10):887-92. PubMed ID: 11100253
[TBL] [Abstract][Full Text] [Related]
19. Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients.
Kleine TO; Benes L; Zöfel P
Brain Res Bull; 2003 Aug; 61(3):265-79. PubMed ID: 12909297
[TBL] [Abstract][Full Text] [Related]
20. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
